Dissemination Core

传播核心

• 批准号: 10715744
• 负责人: Rebecca R. Richards-Kortum
• 金额: $ 10.92万
• 依托单位: RICE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-13 至 2028-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10715744
• 关键词: Acceleration; Address; Adopted; Adoption; Brazil; Caring; Case Study; Cervical Cancer Screening; Clinical; Clinical effectiveness; Collaborations; Communication; Communities; Community Healthcare; Consensus; Development; Device Designs; Device or Instrument Development; Diagnosis; Early Diagnosis; Educational workshop; Engineering; Ensure; Equity; Evaluation; Health Care Sector; Human Papillomavirus; Instruction; Joints; Knowledge; Marketing; Mozambique; Needs Assessment; Patients; Peer Review; Performance; Point of Care Technology; Process; Professional Organizations; Public Health; Public Health Education; Publications; Publishing; Readiness; Research Personnel; Resource-limited setting; Scientist; Screening for cancer; Site; Site Visit; System; Technology; Training; Training Programs; Training and Education; Translations; Visit; Work; World Health; cancer care; cancer health disparity; commercialization; comparative; cost-effectiveness evaluation; diagnostic technologies; effective intervention; effectiveness testing; efficacy testing; evaluation/testing; health care delivery; health care settings; implementation facilitators; implementation science; improved; innovation; medically underserved; novel; novel diagnostics; point of care; point-of-care diagnostics; prototype; routine care; scale up; success; symposium; uptake; webinar

ABSTRACT The traditional staged pipeline for moving innovations from prototype to efficacy and effectiveness testing to real‐world implementation generally results in slow dissemination and uptake of effective interventions and technologies. The CITEC Dissemination Core (DC) will work to accelerate efficient and effective translation and adoption of POC technologies for cancer screening and early detection by engaging in activities that are crucial to achieve optimal adoption and implementation. The DC will work to: 1) ensure that clinical and user needs inform device development and design; 2) proactively assess and address barriers to integrating POC technologies into real‐world health care delivery processes; and 3) train technology developers and end users to develop, evaluate, implement, and commercialize POC technologies for equitable cancer screening and diagnosis. The first aim of the DC is to collaborate with the Technical and Clinical Cores to assess, refine, formally document, and broadly communicate high‐priority unmet clinical needs associated with cancer screening and early detection that are targets for POC technologies to improve equitable cancer screening and early detection. The DC will carry out on‐site needs assessment visits at multiple global sites including medically underserved settings in the US, Brazil and Mozambique. The DC will document and publish consensus POC Technology Needs Statements each year and these will be disseminated broadly in partnership with professional societies. The second aim of the DC is to develop an implementation science roadmap for introducing POC technologies in low‐resource settings based on a case study around implementation of an existing but under‐utilized technology for cervical cancer screening. The third aim of the DC is to provide a portfolio of interdisciplinary training and educational opportunities targeted to technology developers and end‐users to accelerate the development, evaluation, implementation, and commercialization of POC technologies for equitable cancer screening and early detection. We will partner with professional societies to offer engaging, hands‐on pre‐conference workshops. Knowledge generated through these activities will inform and refine the work of other CITEC cores and POCTRN centers and will help ensure that technology prototypes supported by CITEC will have a high rate of success for market adoption, scale‐up, and implementation to address global cancer health disparities.

抽象的 传统的分阶段馈线将创新从原型转变为有效性和有效性测试到现实世界 实施通常会导致缓慢的传播和有效的干预措施和技术的吸收。花旗 传播核心（DC）将努力加速有效的翻译和采用POC技术 癌症筛查和早期检测是通过从事对实现最佳采用和最佳采用至关重要的活动而进行的 执行。 DC将对：1）确保临床和用户需要为设备开发和设计提供信息； 2） 主动评估和解决将POC技术集成到现实世界医疗保健提供过程中的障碍；和 3）培训技术开发人员和最终用户，以开发，评估，实施和商业化POC技术 公平的癌症筛查和诊断。华盛顿特区的第一个目的是与技术和临床核心合作 评估，完善，正式记录并广泛传达与癌症相关的高优先级未满足的临床需求 筛查和早期检测是POC技术改善公平癌症筛查和早期的靶标 检测。 DC将在多个全球地点进行现场需求评估访问，包括医学欠佳 在美国，巴西和莫桑比克的设置。 DC将记录并发布共识POC技术需求 每年的陈述，这些声明将与专业社会合作广泛传播。第二个目标 DC的开发是为了在低资源环境中引入POC技术的实施科学路线图 基于案例研究，涉及实施现有但未充分利用的宫颈癌筛查技术。 华盛顿特区的第三个目标是提供针对的跨学科培训和教育机会的组合 技术开发人员和最终用户加速开发，评估，实施和商业化 用于公平癌症筛查和早期检测的POC技术。我们将与专业社会合作 提供引人入胜的动手会议前研讨会。通过这些活动产生的知识将为和完善 其他Citec核心和Poctrn中心的工作，将有助于确保Citec支持的技术原型 市场采用，扩大规模和实施将取得很高的成功率，以解决全球癌症健康 差异。